Cardiovascular Considerations for the Internist and Hospitalist in the COVID-19 Era

It is clear that existing cardiovascular disease is a major risk factor for COVID-19 and related adverse outcomes. In addition to acute respiratory syndrome, a large cohort also develop myocardial or vascular dysfunction, in part from inflammation and renin angiotensin system activation with increas...

Descripción completa

Detalles Bibliográficos
Autores principales: Massoomi, Michael R., Anderson, R. David, Ahmed, Mustafa M., Dasa, Osama, George, Philip, Miles, William M., Aranda, Juan M., Pepine, Carl J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347494/
https://www.ncbi.nlm.nih.gov/pubmed/32653420
http://dx.doi.org/10.1016/j.amjmed.2020.06.005
_version_ 1783556596786266112
author Massoomi, Michael R.
Anderson, R. David
Ahmed, Mustafa M.
Dasa, Osama
George, Philip
Miles, William M.
Aranda, Juan M.
Pepine, Carl J.
author_facet Massoomi, Michael R.
Anderson, R. David
Ahmed, Mustafa M.
Dasa, Osama
George, Philip
Miles, William M.
Aranda, Juan M.
Pepine, Carl J.
author_sort Massoomi, Michael R.
collection PubMed
description It is clear that existing cardiovascular disease is a major risk factor for COVID-19 and related adverse outcomes. In addition to acute respiratory syndrome, a large cohort also develop myocardial or vascular dysfunction, in part from inflammation and renin angiotensin system activation with increased sympathetic outflow, cardiac arrhythmias, ischemia, heart failure, and thromboembolic complications that portend poor outcomes related to COVID-19. We summarize recent information for hospitalists and internists on the front line of this pandemic regarding its cardiovascular impacts and management and the need for cardiovascular consultation.
format Online
Article
Text
id pubmed-7347494
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-73474942020-07-10 Cardiovascular Considerations for the Internist and Hospitalist in the COVID-19 Era Massoomi, Michael R. Anderson, R. David Ahmed, Mustafa M. Dasa, Osama George, Philip Miles, William M. Aranda, Juan M. Pepine, Carl J. Am J Med Review It is clear that existing cardiovascular disease is a major risk factor for COVID-19 and related adverse outcomes. In addition to acute respiratory syndrome, a large cohort also develop myocardial or vascular dysfunction, in part from inflammation and renin angiotensin system activation with increased sympathetic outflow, cardiac arrhythmias, ischemia, heart failure, and thromboembolic complications that portend poor outcomes related to COVID-19. We summarize recent information for hospitalists and internists on the front line of this pandemic regarding its cardiovascular impacts and management and the need for cardiovascular consultation. Elsevier Inc. 2020-11 2020-07-10 /pmc/articles/PMC7347494/ /pubmed/32653420 http://dx.doi.org/10.1016/j.amjmed.2020.06.005 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Review
Massoomi, Michael R.
Anderson, R. David
Ahmed, Mustafa M.
Dasa, Osama
George, Philip
Miles, William M.
Aranda, Juan M.
Pepine, Carl J.
Cardiovascular Considerations for the Internist and Hospitalist in the COVID-19 Era
title Cardiovascular Considerations for the Internist and Hospitalist in the COVID-19 Era
title_full Cardiovascular Considerations for the Internist and Hospitalist in the COVID-19 Era
title_fullStr Cardiovascular Considerations for the Internist and Hospitalist in the COVID-19 Era
title_full_unstemmed Cardiovascular Considerations for the Internist and Hospitalist in the COVID-19 Era
title_short Cardiovascular Considerations for the Internist and Hospitalist in the COVID-19 Era
title_sort cardiovascular considerations for the internist and hospitalist in the covid-19 era
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347494/
https://www.ncbi.nlm.nih.gov/pubmed/32653420
http://dx.doi.org/10.1016/j.amjmed.2020.06.005
work_keys_str_mv AT massoomimichaelr cardiovascularconsiderationsfortheinternistandhospitalistinthecovid19era
AT andersonrdavid cardiovascularconsiderationsfortheinternistandhospitalistinthecovid19era
AT ahmedmustafam cardiovascularconsiderationsfortheinternistandhospitalistinthecovid19era
AT dasaosama cardiovascularconsiderationsfortheinternistandhospitalistinthecovid19era
AT georgephilip cardiovascularconsiderationsfortheinternistandhospitalistinthecovid19era
AT mileswilliamm cardiovascularconsiderationsfortheinternistandhospitalistinthecovid19era
AT arandajuanm cardiovascularconsiderationsfortheinternistandhospitalistinthecovid19era
AT pepinecarlj cardiovascularconsiderationsfortheinternistandhospitalistinthecovid19era

Ejemplares similares